Oral glucose leads to a differential response in glucose, insulin, and GLP-1 in lean versus obese cats

Domestic Animal Endocrinology

Volumn 38, Issue 2, 2010, Pages 95-102

  Hoenig, M ^a,b   Jordan, E T ^b   Ferguson, D C ^a   de Vries, F ^c  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Glucose tolerance; Incretin; Insulin resistance; Insulin sensitivity; Obesity

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CAT; CAT DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; KINETICS; MALE; METHODOLOGY; OBESITY; SPECIES DIFFERENCE;

ANIMALS; BLOOD GLUCOSE; CAT DISEASES; CATS; FEMALE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN; KINETICS; MALE; OBESITY; SPECIES SPECIFICITY;

EID: 72549115203     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.domaniend.2009.08.004     Document Type: Article

References (57)

1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003; 26:S5-S20.
2. Woerle H.J., Pimenta W.P., and Meyer C. Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin A1C values. Arch Intern Med. 164 (2004) 1627-1632
3. Bacha F., Gungor N., Lee S., and Arslanian S.A. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes?. Diabetes Care. 32 (2009) 100-105
4. Sinha R., Fisch G., Teague B., Tamborlane W.V., Bruna Banyas, Allen K., Savoye M., Rieger V., Taksali S., Barbetta G., Sherwin R.S., and Caprio S. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 346 (2002) 802-810
5. http://www.endotext.org/protocols
6. Libman I.M., Barinas-Mitchell E., Bartucci A., Robertson R., and Arslanian S. Reproducibility of the oral glucose tolerance test in overweight children. J Clin Endocrinol Metab. 93 (2008) 4231-4237
7. Knopf C.F., Cresto J.C., Dujovne I.L., Ramos O., and de Majo S.F. Oral glucose tolerance test in 100 normal children. Acta Diabetol Lat. 14 (1977) 95-103
8. http://www.diabetes.org/about-diabetes.jsp
9. Kaneko J.J. Carbohydrate metabolism and its diseases. In: Kaneko J.J. (Ed). Clinical Biochemistry of Domestic Animals. 4th ed. (1989), Academic Press, San Diego, CA 44-85
10. Church D.B. A comparison of intravenous and oral glucose tolerance tests in the dog. Res Vet Sci. 29 (1980) 353-356
11. Irvine A.J., Butterwick R., Watson T., Millward D., and Morgan L.M. Determination of insulin sensitivity in the dog: an assessment of three methods. J Nutr. 132 (2002) 1706S-1708S
12. Lechin F., Coll-García E., van der Dijs B., Bentolila A., Peña F., and Rivas C. The effects of dopaminergic blocking agents on the glucose tolerance test in 6 humans and 6 dogs. Cell Mol Life Sci. 35 (1979) 876-877
13. Kreyman B., Ghatei M.A., Williams G., and Bloom S.R. Glucagon like peptide-1 7-36: A physiological incretin in man. Lancet. 2 (1987) 1300-1304
14. Eissele R., Göke R., Willemer S., Harthus H.P., Vermeer H., Arnold R., and Göke B. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest. 22 (1992) 283-291
15. Theodorakis M.J. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Am J Physiol. 290 (2006) E550-E559
16. Mannucci E., Ognibene A., Cremasco F., Bardini G., Mencucci A., Pierazzuoli E., Ciani S., Fanelli A., Messeri G., and Rotella C.M. Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus. Diabet Med. 17 (2000) 713-719
17. Ranganath L.R., Beety J.M., Morgan L.M., Wright J.W., Howland R., and Marks V. Attenuated GLP-1 secretion in obesity: cause or consequence?. Gut. 38 (1996) 916-919
18. Kjems L.L., Holst J.J., Vølund A., and Madsbad S. The influence of GLP-1 on glucose-stimulated insulin secretion: effects on ß-cell sensitivity in type 2 and nondiabetic subjects. Diabetes. 52 (2003) 380-386
19. Nauck M.A., Bartels E., Ørskov C., Ebert R., and Creutzfeldt W. Additive insulinotropic effects of exogenous synthetic human gastic inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. J Clin Endocrinol Metab. 76 (1993) 912-917
20. Orskov C., Wettergren A., and Holst J.J. Biological effects andmetabolic effects of glucagon-like peptide-1 7-36 amideand glucagon-like peptide-1 7-36 in healthy subjects are indistinguishable. Diabetes. 42 (1993) 658-661
21. Gutniak M., Orskov C., Holst J.J., Ahren B., and Efendic S. Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetesmellitus. N Engl J Med. 326 (1992) 1316-1322
22. Flint A., Raben A., Astrup A., and Holst R.R. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest. 101 (1998) 515-520
23. Hoenig M., Thomaseth K., Brandao J., Waldron M., and Ferguson D.C. Assessment and mathematical modeling of glucose turnover and insulin sensitivity in lean and obese cats. Domest Anim Endocrinol. 31 (2006) 573-589
24. Hoenig M., Thomaseth K., Waldron M., and Ferguson D.C. Fatty acid turnover, substrate oxidation, and heat production in lean and obese cats during the euglycemic hyperinsulinemic clamp. Domest Anim Endocrinol. 32 (2007) 329-338
25. Hoenig M., Thomaseth K., Waldron M., and Ferguson D.C. Insulin sensitivity, fat distribution and adipocytokine response to different diets in lean, and obese cats before and after weight loss. Am J Physiol. 292 (2007) R227-R234
26. Nelson R.W., Himsel C.A., Feldman E.C., and Bottoms G.D. Glucose tolerance and insulin response in normal-weight and obese cats. Am J Vet Res. 51 (1990) 1357-1362
27. Hoenig M., and Ferguson D.C. Impairment of glucose tolerance in hyperthyroid cats. J Endocrinol. 121 (1989) 249-251
28. Anderson T.W., and Darling D.A. Asymptotic theory of certain "goodness-of-fit" criteria based on stochastic processes. Ann Math Stat. 23 (1952) 193-212
29. Shapiro S.S., and Wilk M.B. An analysis of variance test for normality (complex samples). Biometrika. 52 (1965) 591-611
30. Callaham M., Wears R.L., and Weber E. Journal prestige, publication bias, and other characteristics associated with citation of published studies in peer-reviewed journals. JAMA. 287 (2002) 2847-2850
31. Steiger J.H. Review of SYSTAT, the system for statistics, by Leland Wilkinson. Multivariat Behavior Res. 23 (1988) 133-139
32. Arfsten D.P., Still K.R., Wilfong E.R., Johnson E.W., McInturf S.M., Eggers J.S., Schaeffer D.J., and Bekkedal M.Y. Two-generation reproductive toxicity study of implanted depleted uranium (DU) in CD rats. J Toxicol Environ Health A. 72 (2009) 410-427
33. Mandel R. Software reviews: Resampling stats publisher. Soc Sci Comput Rev. 15 (1997) 305-308
34. Drapeau C., Ma H., Yang Z., Tang L., Hoffman R.M., and Schaeffer D.J. The stem cell mobilizer (R) does not promote tumor growth in an orthotopic model of human breast cancer. Anticancer Res. 29 (2009) 443-447
35. Marsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with with the euglycemic insulin clamp. Diabetes Care. 22 (1999) 1462-1470
36. Cardenas M.L. Comparative biochemistry of glucokinase. In: Matschinsky F.M., and Magnuson M.A. (Eds). Glucokinase and Glycemic Disease: From Basics to Novel Therapeutics (2004), Karger, Basel, Switzerland 31-41
37. Tanaka A., Inoue A., Takeguchi A., Washizu T., Bonkobara M., and Arai T. Comparison of expression of glucokinase gene and activities of enzymes related to glucose metabolism in livers between dog and cat. Vet Res Commun. 29 (2005) 477-485
38. Hosokawah H., Hosokawa Y.A., and Leahy J. Upregulated hexokinase activity in isolated islets from diabetic 90% pancreatectomized rats. Diabetes. 44 (1995) 1328-1333
39. Cockburn B.N., Ostrega D.M., Sturis J., Kubstrup C., Polonsky K.S., and Bell G.I. Changes in pancreatic islet glucokinase and hexokinase activities with increasing age, obesity, and the onset of diabetes. Diabetes. 46 (1997) 1434-1439
40. Washizu T., Tanaka A., Sako T., Washizu M., and Arai T. Comparison of the activities of enzymes related to glycolysis and gluconeogenesis in the liver of dogs and cats. Res Vet Sci. 67 (1999) 205-206
41. Lin H.C., Elashoff J.D., Gu Y.-G., and Meyer J.H. Effect of meal volume on gastric emptying. Neurogastroenterol Motil. 4 (1992) 157-163
42. Noakes T.D., Rehrer N.J., and Maughan R. The importance of volume in regulating gastric emptying. Med Sci Sports. 23 (1991) 307-313
43. Bernstein R.S., Thornton J.C., Yang M.U., Wang J., Redmond A.M., Pierson R.N., Xavier PiSunyer F., and Van Itallie T.B. Prediction of the resting metabolic rate in obese patients. Am J Clin Nutr. 37 (1983) 595-602
44. Boer J.O., de, Es A.J.H., van, Raaij J.M.A., van, and Hautvast J.G.A.J. Energy requirements and energy expenditure of lean and overweight women, measured by indirect calorimetry. Am J Clin Nutr. 46 (1987) 13-21
45. Molnar D., and Schutz Y. The effect of obesity, age, puberty and gender on resting metabolic rate in children and adolescents. Eur J Pediatrics. 156 (1997) 376-381
46. Hoenig M., and Rand J. Feline obesity. In: August J.R. (Ed). Consultations in Feline Internal Medicine (2006), WB Saunders, Philadelphia 175-182
47. Nauck M.A., El Ouaghlidi A., Gabrys B., Hucking K., Holst J.J., Deacon C.F., Gallwitz B., Schmidt W.E., and Meier J.J. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes. Regul Pept. 122 (2004) 209-217
48. Fukase N., Igarashi M., Takahashi H., Manaka H., Yamatani K., and Daimon M. Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients. Diabet Med. 10 (1993) 44-49
49. Vilsboll T., Krarup T., Sonne J., Madsbad S., Volund A., Juul A.G., and Holst J.J. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab. 88 (2003) 2706-2713
50. le Roux C., Welbourn R., Werling M., Osborne A., Kokkinos A., Laurenius A., Lönroth H., Fändriks L., Ghatei M.A., Bloom S., and Olbers T. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 246 (2007) 780-785
51. Laferrere B., Heshka S., Wang K., Khan Y., McGinty J., Teixeira J., Hart A.B., and Olivan B. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care. 30 (2007) 1709-1716
52. Lugari R., Dei Cas A., Ugolotti D., Barilli C., Camellini G., Ganzerla C., Luciani A., Salerni B., Mittenperger F., Nodari S., Gnudi A., and Zandomeneghi R. Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion. Horm Metab Res. 36 (2004) 111-115
53. Rask E., Olsson T., Söderberg S., Johnson O., Seckl J., Holst J.J., and Ahrén B. Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men. Diabetes Care. 24 (2001) 1640-1645
54. Kley S., Hoenig M., Glushka J., Jin E.S., Burgess S.C., Waldron M., Jordan E.T., Prestegard J.H., Ferguson D.C., Wu S., and Olson D.E. The impact of obesity, sex, and diet on hepatic glucose production in cats. Am J Physiol Regul Integr Comp Physiol 296 (2009) R936-R943
55. Hoenig M., Alexander S., Holson J., and Ferguson D.C. Influence of glucose dosage on interpretation of intravenous glucose tolerance tests in lean and obese cats. J Vet Intern Med. 16 (2002) 529-532
56. Sirinek K.R., Pace W.G., Crockett S.E., O'Dorisio T.M., Mazzaferri E.L., and Cataland S. Insulin-induced attenuation of glucose-stimulated gastric inhibitory polypeptide secretion. Am J Surg. 135 (1978) 151-155
57. http://www.millipore.com/immunodetection/id3/elisa